Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study.
This study was meticulously designed to evaluate the performance and safety of a novel wound dressing technology in real-world settings. Emphasizing safety and performance, the study aimed to gather comprehensive data on the expected outcomes and to vigilantly monitor for any expected and unexpected adverse events. The study was completed ahead of schedule.
The success of this study is a testament to the collaborative effort of our dedicated team and the participating medical professionals, who navigated these challenges with expertise and commitment.
If you are interested in any type of medical devices study, please do not hesitate to contact us.
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
Copyright @ 2026 Axcellant